| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| cyproheptadine | muscarinic acetylcholine receptor m1 | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Vascular Headaches[MeSHID:D014653] Pruritus[MeSHID:D011537] Serotonin Syndrome[MeSHID:D020230] Desire for food[MeSHID:D001066] anaphylaxis[MeSHID:D000707] Conjunctivitis[MeSHID:D003231] Rhinitis[MeSHID:D012220] Urticaria[MeSHID:D014581] Off-Label Use[MeSHID:D056687] Malignant Carcinoid Syndrome[MeSHID:D008303] Prescription procedure[MeSHID:D055656] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | antagonist |
| cyproheptadine | muscarinic acetylcholine receptor m2 | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Vascular Headaches[MeSHID:D014653] Pruritus[MeSHID:D011537] Serotonin Syndrome[MeSHID:D020230] Desire for food[MeSHID:D001066] anaphylaxis[MeSHID:D000707] Conjunctivitis[MeSHID:D003231] Rhinitis[MeSHID:D012220] Urticaria[MeSHID:D014581] Off-Label Use[MeSHID:D056687] Malignant Carcinoid Syndrome[MeSHID:D008303] Prescription procedure[MeSHID:D055656] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | antagonist |
| cyproheptadine | muscarinic acetylcholine receptor m3 | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Vascular Headaches[MeSHID:D014653] Pruritus[MeSHID:D011537] Serotonin Syndrome[MeSHID:D020230] Desire for food[MeSHID:D001066] anaphylaxis[MeSHID:D000707] Conjunctivitis[MeSHID:D003231] Rhinitis[MeSHID:D012220] Urticaria[MeSHID:D014581] Off-Label Use[MeSHID:D056687] Malignant Carcinoid Syndrome[MeSHID:D008303] Prescription procedure[MeSHID:D055656] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | antagonist |
| cyproheptadine | histamine h1 receptor | small molecule | Successful target | TTD , drugbank , DGIDB | Disease Management[MeSHID:D019468] Vascular Headaches[MeSHID:D014653] Pruritus[MeSHID:D011537] Serotonin Syndrome[MeSHID:D020230] Desire for food[MeSHID:D001066] anaphylaxis[MeSHID:D000707] Conjunctivitis[MeSHID:D003231] Rhinitis[MeSHID:D012220] Urticaria[MeSHID:D014581] Off-Label Use[MeSHID:D056687] Malignant Carcinoid Syndrome[MeSHID:D008303] Prescription procedure[MeSHID:D055656] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.23 | approved | antagonist |
| cyproheptadine | histamine h2 receptor | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Vascular Headaches[MeSHID:D014653] Pruritus[MeSHID:D011537] Serotonin Syndrome[MeSHID:D020230] Desire for food[MeSHID:D001066] anaphylaxis[MeSHID:D000707] Conjunctivitis[MeSHID:D003231] Rhinitis[MeSHID:D012220] Urticaria[MeSHID:D014581] Off-Label Use[MeSHID:D056687] Malignant Carcinoid Syndrome[MeSHID:D008303] Prescription procedure[MeSHID:D055656] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | antagonist |
| cyproheptadine | 5-hydroxytryptamine receptor 2a | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Vascular Headaches[MeSHID:D014653] Pruritus[MeSHID:D011537] Serotonin Syndrome[MeSHID:D020230] Desire for food[MeSHID:D001066] anaphylaxis[MeSHID:D000707] Conjunctivitis[MeSHID:D003231] Rhinitis[MeSHID:D012220] Urticaria[MeSHID:D014581] Off-Label Use[MeSHID:D056687] Malignant Carcinoid Syndrome[MeSHID:D008303] Prescription procedure[MeSHID:D055656] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.34 | approved | antagonist |
| cyproheptadine | 5-hydroxytryptamine receptor 2b | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Vascular Headaches[MeSHID:D014653] Pruritus[MeSHID:D011537] Serotonin Syndrome[MeSHID:D020230] Desire for food[MeSHID:D001066] anaphylaxis[MeSHID:D000707] Conjunctivitis[MeSHID:D003231] Rhinitis[MeSHID:D012220] Urticaria[MeSHID:D014581] Off-Label Use[MeSHID:D056687] Malignant Carcinoid Syndrome[MeSHID:D008303] Prescription procedure[MeSHID:D055656] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | antagonist |
| cyproheptadine | 5-hydroxytryptamine receptor 2c | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Vascular Headaches[MeSHID:D014653] Pruritus[MeSHID:D011537] Serotonin Syndrome[MeSHID:D020230] Desire for food[MeSHID:D001066] anaphylaxis[MeSHID:D000707] Conjunctivitis[MeSHID:D003231] Rhinitis[MeSHID:D012220] Urticaria[MeSHID:D014581] Off-Label Use[MeSHID:D056687] Malignant Carcinoid Syndrome[MeSHID:D008303] Prescription procedure[MeSHID:D055656] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | antagonist |
| cyproheptadine | 5-hydroxytryptamine receptor 7 | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Vascular Headaches[MeSHID:D014653] Pruritus[MeSHID:D011537] Serotonin Syndrome[MeSHID:D020230] Desire for food[MeSHID:D001066] anaphylaxis[MeSHID:D000707] Conjunctivitis[MeSHID:D003231] Rhinitis[MeSHID:D012220] Urticaria[MeSHID:D014581] Off-Label Use[MeSHID:D056687] Malignant Carcinoid Syndrome[MeSHID:D008303] Prescription procedure[MeSHID:D055656] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.29 | approved | antagonist |
| click here to return to the previous page | ||||||||